WASHINGTON, D.C. – AdvaMed, the Medtech Association, today announced that its board of directors has unanimously approved revisions to the AdvaMed Code of Ethics on Interactions with Health Care Professionals.
The AdvaMed Code provides medtech companies guidance on ethical interactions and relationships with health care professionals, based on the cornerstone values of innovation, education, integrity, respect, responsibility, and transparency.
“With the fast-paced development of digital health technologies transforming health care, this Code update recognizes the industry’s longstanding commitment to delivering critical technologies to patients safely and effectively,” said Peter J. Arduini, president and CEO of GE HealthCare and chairman of the AdvaMed board of directors. “Integrity in business is paramount to fostering patient trust and driving innovation to help clinicians improve the lives of the patients we serve.”
“With these updates to the Code, AdvaMed reaffirms our dedication to safeguarding patient data so that patients can confidently benefit from innovative digital health technologies that are improving patient outcomes worldwide,” said Scott Whitaker, president and CEO of AdvaMed.
Recognizing the expansion of data-driven technologies, the updated Code expands on guidance for handling data responsibly, ethically, and transparently to deliver trustworthy technologies to patients: data use to benefit patient access and outcomes; protecting patient privacy; and managing data responsibly in accordance with best practices and international standards.
The revised AdvaMed Code will take effect November 1, 2025. Complete information about AdvaMed’s Code and related health compliance issues is available here.